Rapid Micro Biosystems (RPID)
(Delayed Data from NSDQ)
$0.85 USD
+0.01 (1.50%)
Updated Aug 29, 2024 03:57 PM ET
2-Buy of 5 2
B Value C Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
RPID 0.85 +0.01(1.50%)
Will RPID be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RPID based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RPID
What's in Store for Cooper Companies (COO) in Q3 Earnings?
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Tops Revenue Estimates
RPID: What are Zacks experts saying now?
Zacks Private Portfolio Services
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
Edwards Lifesciences (EW) Q1 Earnings and Revenues Top Estimates
Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Tops Revenue Estimates
Other News for RPID
Morgan Stanley Remains a Hold on Rapid Micro Biosystems (RPID)
Rapid Micro Biosystems Inc (RPID) Q2 2024 Earnings Call Transcript Highlights: Record Revenue ...
Buy Rating Affirmed for Rapid Micro Biosystems Amid Strong Revenue Growth and Strategic Cost-Saving Initiatives
Rapid Micro Biosystems, Inc. (RPID) Q2 2024 Earnings Call Transcript
Rapid Micro Biosystems Reports Second Quarter 2024 Financial Results